Small Molecule Antagonists of the WNT/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0033976
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Identification of Tumor-Initiating Cells in a P53-Null Mouse Model of Breast Cancer

Cancer Research
Cancer ResearchOncology
2008English

Proteome and Transcriptome Profiles of a Her2/Neu-Driven Mouse Model of Breast Cancer

Proteomics - Clinical Applications
Clinical Biochemistry
2011English

WNT Signaling in Human and Mouse Breast Cancer: Focusing on WNT Ligands, Receptors and Antagonists

Cancer Science
Cancer ResearchMedicineOncology
2018English

WNT-Beta-Catenin Pathway Signals Metastasis-Associated Tumor Cell Phenotypes in Triple Negative Breast Cancers

Oncotarget
Oncology
2016English

CDK3, Target of miR-4469, Suppresses Breast Cancer Metastasis via Inhibiting WNT/Β-Catenin Pathway

Oncotarget
Oncology
2017English

MENA Is a Transcriptional Target of the WNT/Beta-Catenin Pathway

PLoS ONE
Multidisciplinary
2012English

Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

PLoS ONE
Multidisciplinary
2012English

Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy via Suppressing WNT/Β-Catenin Signaling Pathway

PLoS ONE
Multidisciplinary
2014English

HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy